SOD1 transcriptional and posttranscriptional regulation and its potential implications in ALS

Neurology Research International

Volumn 2011, Issue , 2011, Pages

  Milani, Pamela ^a,b   Gagliardi, Stella ^a   Cova, Emanuela ^a   Cereda, Cristina ^a  

^a C MONDINO NATIONAL NEUROLOGICAL INSTITUTE   (Italy)

^b UNIVERSITY OF PAVIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 82255171356     PISSN: 20901852     EISSN: 20901860     Source Type: Journal    
DOI: 10.1155/2011/458427     Document Type: Review

References (82)

1. H. E. Parge, R. A. Hallewell, and J. A. Tainer, "Atomic structures of wild-type and thermostablemutant recombinant human Cu,Zn superoxide dismutase," Proceedings of the National Academy of Sciences of the United States of America, vol. 89, no. 13, pp. 6109-6113, 1992.
2. T. Mann and D. Kleinin, "Homocuprein and heptacuprein, coppe-protein compound of bloods and liver in mammals," Proceedings of the Royal Society B, vol. 126, pp. 303-315, 1938.
3. J. M. McCord and I. Fridovich, "Superoxide dismutase. An enzymic function for erythrocuprein (hemocuprein)," Journal of Biological Chemistry, vol. 244, no. 22, pp. 6049-6055, 1969.
4. I. Fridovich, "Superoxide dismutases," Annual Review of Biochemistry, vol. 44, pp. 147-159, 1975.
5. L. Y. Chang, J.W. Slot,H. J.Geuze, and J.D. Crapo, "Molecular immunocytochemistry of the CuZn superoxide dismutase in rat hepatocytes," Journal of Cell Biology, vol. 107, no. 6, part 1, pp. 2169-2179, 1988. (Pubitemid 19015096)
6. E. C. Chang, B. F. Crawford, Z. Hong, T. Bilinski, and D. J. Kosman, "Genetic and biochemical characterization of Cu,Zn superoxide dismutase mutants in Saccharomyces cerevisiae," Journal of Biological Chemistry, vol. 266, no. 7, pp. 4417-4424, 1991. (Pubitemid 21909372)
7. F. M. F. Alameddine and A. M. Zafari, "Genetic polymorphisms and oxidative stress in heart failure," Congestive Heart Failure, vol. 8, no. 3, pp. 157-172, 2002.
8. L. W. Oberley and G. R. Buettner, "Role of superoxide dismutase in cancer: A review," Cancer Research, vol. 39, no. 4, pp. 1141-1149, 1979. (Pubitemid 9183825)
9. M. Flekac, J. Skrha, J. Hilgertova, Z. Lacinova, and M. Jarolimkova, "Gene polymorphisms of superoxide dismutases and catalase in diabetes mellitus," BMC Medical Genetics, vol. 9, article 30, 2008.
10. R. de la Torre, A. Casado, E. López-Fernández, D. Carrascosa, V. Ramírez, and J. Sáez, "Overexpression of copper-zinc superoxide dismutase in trisomy 21," Experientia, vol. 52, no. 9, pp. 871-873, 1996. (Pubitemid 26326394)
11. D. R. Rosen, T. Siddique, D. Patterson et al., "Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis," Nature, vol. 362, no. 6415, pp. 59-62, 1993. (Pubitemid 23087289)
12. H. Ohno, S. Iizuka, and T. Kondo, "The levels of superoxide dismutase, catalase, and carbonic anhydrase in erythrocytes of patients with Down's syndrome," Klinische Wochenschrift, vol. 62, no. 6, pp. 287-288, 1984. (Pubitemid 14155192)
13. D. Levanon, J. Lieman-Hurwitz, N. Dafni et al., "Architecture and anatomy of the chromosomal locus in human chromosome 21 encoding the Cu/Zn superoxide dismutase," The EMBO Journal, vol. 4, no. 1, pp. 77-84, 1985.
14. S. J. Seo, H. T. Kim, G. Cho, H. M. Rho, and G. Jung, "Sp1 and C/EBP-related factor regulate the transcription of human Cu/Zn SOD gene," Gene, vol. 178, no. 1-2, pp. 177-185, 1996. (Pubitemid 26377148)
15. H. Y. Yoo, M. S. Chang, and H. M. Rho, "Heavy metalmediated activation of the rat Cu/Zn superoxide dismutase gene via a metal-responsive element," Molecular and General Genetics, vol. 262, no. 2, pp. 310-313, 1999. (Pubitemid 29440766)
16. H. Y. Yoo, M. S. Chang, and H. M. Rho, "Induction of the rat Cu/Zn superoxide dismutase gene through the peroxisome proliferator-responsive element by arachidonic acid," Gene, vol. 234, no. 1, pp. 87-91, 1999. (Pubitemid 29291647)
17. H. Y. Yoo, M. S. Chang, and H. M. Rho, "The activation of the rat copper/zinc superoxide dismutase gene by hydrogen peroxide through the hydrogen peroxide-responsive element and by paraquat and heat shock through the same heat shock element," Journal of Biological Chemistry, vol. 274, no. 34, pp. 23887-23892, 1999.
18. Y. H. Kim, K. H. Park, and H. M. Rho, "Transcriptional activation of the Cu,Zn-superoxide dismutase gene through the AP2 site by ginsenoside Rb extracted from a medicinal plant, Panax ginseng," Journal of Biological Chemistry, vol. 271, no. 40, pp. 24539-24543, 1996. (Pubitemid 26333191)
19. L. Sherman, N. Dafni, J. Lieman Hurwitz, and Y. Groner, "Nucleotide sequence and expression of human chromosome 21-encoded superoxide dismutase mRNA," Proceedings of the National Academy of Sciences of the United States of America, vol. 80, no. 181, pp. 5465-5469, 1983. (Pubitemid 14242869)
20. Y. Groner, J. Lieman-Hurwitz, N. Dafni et al., "Molecular structure and expression of the gene locus on chromosome 21 encoding the Cu/Zn superoxide dismutase and its relevance to Down syndrome," Annals of the New York Academy of Sciences, vol. 450, pp. 133-156, 1985. (Pubitemid 15070370)
21. S. J. Seo, S. S. Kang, G. Cho, H.M. Rho, and G. Jung, "C/EBP? and C/EBP? play similar roles in the transcription of the human Cu/Zn SOD gene," Gene, vol. 203, no. 1, pp. 11-15, 1997. (Pubitemid 27520648)
22. T. C. Hour, Y. L. Lai, C. I. Kuan et al., "Transcriptional upregulation of SOD1 by CEBPD: A potential target for cisplatin resistant human urothelial carcinoma cells," Biochemical Pharmacology, vol. 80, no. 3, pp. 325-334, 2010.
23. M. R. Briggs, J. T. Kadonaga, S. P. Bell, and R. Tjian, "Purification and biochemical characterization of the promoterspecific transcription factor, Sp1," Science, vol. 234, no. 4772, pp. 47-52, 1986. (Pubitemid 17171544)
24. V. Afonso, G. Santos, P. Collin et al., "Tumor necrosis factor-? down-regulates human Cu/Zn superoxide dismutase 1 promoter via JNK/AP-1 signaling pathway," Free Radical Biology and Medicine, vol. 41, no. 5, pp. 709-721, 2006. (Pubitemid 44163407)
25. X. Cao, G. R. Guy, V. P. Sukhatme, and Y. H. Tan, "Regulation of the Egr-1 gene by tumor necrosis factor and interferons in primary human fibroblasts," Journal of Biological Chemistry, vol. 267, no. 2, pp. 1345-1349, 1992.
26. L. R. Chaudhary, S. L. Cheng, and L. V. Avioli, "Induction of early growth response-1 gene by interleukin-1? and tumor necrosis factor-? in normal human bone marrow stromal and osteoblastic cells: regulation by a protein kinase C inhibitor," Molecular and Cellular Biochemistry, vol. 156, no. 1, pp. 69-77, 1996.
27. X. Zhang and Y. Liu, "Suppression of HGF receptor gene expression by oxidative stress is mediated through the interplay between Sp1 and Egr-1," American Journal of Physiology, vol. 284, no. 6, pp. F1216-F1225, 2003. (Pubitemid 36578449)
28. N. A. Franken, R. ten Cate, C. van Bree, and J. Haveman, "Induction of the early response protein EGR-1 in human tumour cells after ionizing radiation is correlated with a reduction of repair of lethal lesions and an increase of repair of sublethal lesions," International Journal of Oncology, vol. 24, no. 4, pp. 1027-1031, 2004.
29. I. B. Copland and M. Post, "Stretch-activated signaling pathways responsible for early response gene expression in fetal lung epithelial cells," Journal of Cellular Physiology, vol. 210, no. 1, pp. 133-143, 2007. (Pubitemid 44904708)
30. E. Minc, P. de Coppet, P. Masson et al., "The human copperzinc superoxide dismutase gene (SOD1) proximal promoter is regulated by Sp1, Egr-1, and WT1 via non-canonical binding sites," Journal of Biological Chemistry, vol. 274, no. 1, pp. 503-509, 1999. (Pubitemid 29035089)
31. S. Baldelli, K. Aquilano, G. Rotilio, and M. R. Ciriolo, "Glutathione and copper, zinc superoxide dismutase are modulated by overexpression of neuronal nitric oxide synthase," International Journal of Biochemistry and Cell Biology, vol. 40, no. 11, pp. 2660-2670, 2008.
32. B. K. Meyer and G. H. Perdew, "Characterization of the AhRhsp90-XAP2 core complex and the role of the immunophilinrelated protein XAP2 in AhR stabilization," Biochemistry, vol. 38, no. 28, pp. 8907-8917, 1999.
33. A. Kazlauskas, L. Poellinger, and I. Pongratz, "Evidence that the co-chaperone p23 regulates ligand responsiveness of the dioxin (aryl hydrocarbon) receptor," Journal of Biological Chemistry, vol. 274, no. 19, pp. 13519-13524, 1999.
34. J. Mimura and Y. Fujii-Kuriyama, "Functional role of AhR in the expression of toxic effects by TCDD," Biochimica et Biophysica Acta, vol. 1619, no. 3, pp. 263-268, 2003. (Pubitemid 36160604)
35. C. L. Wilson and S. Safe, "Mechanisms of ligand-induced aryl hydrocarbon receptor-mediated biochemical and toxic responses," Toxicologic Pathology, vol. 26, no. 5, pp. 657-671, 1998. (Pubitemid 28462718)
36. T. A. Nguyen, D. Hoivik, J. E. Lee, and S. Safe, "Interactions of nuclear receptor coactivator/corepressor proteins with the aryl hydrocarbon receptor complex," Archives of Biochemistry and Biophysics, vol. 367, no. 2, pp. 250-257, 1999. (Pubitemid 29394172)
37. J. S. Cho, M. S. Chang, and H. M. Rho, "Transcriptional activation of the human Cu/Zn superoxide dismutase gene by 2,3,7,8-tetrachlorodibenzo-p- dioxin through the xenobioticresponsive element," Molecular Genetics and Genomics, vol. 266, no. 1, pp. 133-141, 2001. (Pubitemid 32778672)
38. J. Li, M. J. Calkins, D. A. Johnson, and J. A. Johnson, "Role of Nrf2-dependent ARE-driven antioxidant pathway in neuroprotection," Methods in Molecular Biology, vol. 399, pp. 67-78, 2007.
39. W. O. Osburn and T. W. Kensler, "Nrf2 signaling: an adaptive response pathway for protection against environmental toxic insults," Mutation Research, vol. 659, no. 1-2, pp. 31-39, 2008.
40. W. Li and A. N. Kong, "Molecular mechanisms of Nrf2-mediated antioxidant response," Molecular Carcinogenesis, vol. 48, no. 2, pp. 91-104, 2009.
41. T. Nguyen, P. Nioi, and C. B. Pickett, "The Nrf2-antioxidant response element signaling pathway and its activation by oxidative stress," Journal of Biological Chemistry, vol. 284, no. 20, pp. 13291-13295, 2009.
42. E. Y. Park and H. M. Rho, "The transcriptional activation of the human copper/zinc superoxide dismutase gene by 2,3,7,8-tetrachlorodibenzo-p- dioxin through two different regulator sites, the antioxidant responsive element and xenobiotic responsive element," Molecular and Cellular Biochemistry, vol. 240, no. 1-2, pp. 47-55, 2002. (Pubitemid 35385819)
43. H. Dreger, K.Westphal, N.Wilck et al., "Protection of vascular cells from oxidative stress by proteasome inhibition depends on Nrf2," Cardiovascular Research, vol. 85, no. 2, pp. 395-403, 2010.
44. E. O'Dea and A. Hoffmann, "The regulatory logic of the NFkappaB signaling system.," Cold Spring Harbor Perspectives in Biology, vol. 2, no. 1, Article ID a000216, 2010.
45. S. Ghosh and M. S. Hayden, "New regulators of NF-?B in inflammation,"Nature Reviews Immunology, vol. 8, no. 11, pp. 837-848, 2008.
46. S. Vallabhapurapu and M. Karin, "Regulation and function of NF-?B transcription factors in the immune system," Annual Review of Immunology, vol. 27, pp. 693-733, 2009.
47. R. Schreck, P. Rieber, and P. A. Baeuerle, "Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-?B transcription factor and HIV-1," The EMBO Journal, vol. 10, no. 8, pp. 2247-2258, 1991. (Pubitemid 21905698)
48. C. K. Sen and L. Packer, "Antioxidant and redox regulation of gene transcription," FASEB Journal, vol. 10, no. 7, pp. 709-720, 1996. (Pubitemid 26172817)
49. S. K. Manna, H. J. Zhang, T. Yan, L. W. Oberley, and B. B. Aggarwal, "Overexpression of manganese superoxide dismutase suppresses tumor necrosis factor-induced apoptosis and activation of nuclear transcription factor-?B and activated protein-1," Journal of Biological Chemistry, vol. 273, no. 21, pp. 13245-13254, 1998. (Pubitemid 28246897)
50. N. Li and M. Karin, "Is NF-?B the sensor of oxidative stress?" FASEB Journal, vol. 13, no. 10, pp. 1137-1143, 1999.
51. A. I. Rojo,M. Salinas, D. Martín, R. Perona, and A. Cuadrado, "Regulation of Cu/Zn-superoxide dismutase expression via the phosphatidylinositol 3 kinase/Akt pathway and nuclear factor-?B," Journal of Neuroscience, vol. 24, no. 33, pp. 7324-7334, 2004. (Pubitemid 39100701)
52. T. Tagami, L. D. Madison, T. Nagaya, and J. L. Jameson, "Nuclear receptor corepressors activate rather than suppress basal transcription of genes that are negatively regulated by thyroid hormone," Molecular and Cellular Biology, vol. 17, no. 5, pp. 2642-2648, 1997. (Pubitemid 27175146)
53. D. L. Bodenner, M. A. Mroczynski, B. D. Weintraub, S. Radovick, and F. E. Wondisford, "A detailed functional and structural analysis of a major thyroid hormone inhibitory element in the human thyrotropin subunit gene," Journal of Biological Chemistry, vol. 266, no. 32, pp. 21666-21673, 1991. (Pubitemid 121000232)
54. G.M. Santos,V. Afonso, G. B. Barra et al., "Negative regulation of superoxide dismutase-1 promoter by thyroid hormone," Molecular Pharmacology, vol. 70, no. 3, pp. 793-800, 2006. (Pubitemid 44268436)
55. C. Andreassi and A. Riccio, "To localize or not to localize: mRNA fate is in 3-UTR ends," Trends in Cell Biology, vol. 19, no. 9, pp. 465-474, 2009.
56. A. Kilk, "Human CuZn superoxide dismutase enzymatic activity in cells is regulated by the length of the mRNA," FEBS Letters, vol. 362, no. 3, pp. 323-327, 1995.
57. G. Shaw and R. Kamen, "A conserved AU sequence from the 3- untranslated region of GM-CSF mRNA mediates selective mRNA degradation," Cell, vol. 46, no. 5, pp. 659-667, 1986.
58. A. Pascale,M. Amadio, and A. Quattrone, "Defining a neuron: neuronal ELAV proteins," Cellular and Molecular Life Sciences, vol. 65, no. 1, pp. 128-140, 2008. (Pubitemid 351152226)
59. R. S. Pillai, S. N. Bhattacharyya, and W. Filipowicz, "Repression of protein synthesis by miRNAs: how many mechanisms?" Trends in Cell Biology, vol. 17, no. 3, pp. 118-126, 2007. (Pubitemid 46357525)
60. W. Filipowicz, S.N. Bhattacharyya, andN. Sonenberg, "Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight?" Nature Reviews Genetics, vol. 9, no. 2, pp. 102-114, 2008.
61. Q. Wang, Y. Wang, A. W. Minto et al., "MicroRNA-377 is upregulated and can lead to increased fibronectin production in diabetic nephropathy," FASEB Journal, vol. 22, no. 12, pp. 4126-4135, 2008.
62. T. Siddique, D. A. Fiolewicz, M. A. Pericak-Vance et al., "Linkage of a gene causing familial amyotrophic lateral sclerosis to chromosome 21 and evidence of genetic-locus heterogeneity," The New England Journal of Medicine, vol. 324, no. 20, pp. 1381-1384, 1991.
63. H. X. Deng, A. Hentati, J. A. Tainer et al., "Amyotrophic lateral sclerosis and structural defects in Cu,Zn superoxide dismutase," Science, vol. 261, no. 5124, pp. 1047-1051, 1993. (Pubitemid 23300865)
64. P. M. Andersen, "Amyotrophic lateral sclerosis associated with mutations in the CuZn superoxide dismutase gene," Current Neurology and Neuroscience Reports, vol. 6, no. 1, pp. 37-46, 2006. (Pubitemid 43154251)
65. R. Wroe, A. Wai-Ling Butler, P. M. Andersen, J. F. Powell, and A. Al-Chalabi, "ALSOD: The amyotrophic lateral sclerosis online database," Amyotrophic Lateral Sclerosis, vol. 9, no. 4, pp. 249-250, 2008.
66. P. M. Andersen, K. B. Sims, W. W. Xin et al., "Sixteen novel mutations in the Cu/Zn superoxide dismutase gene in amyotrophic lateral sclerosis: A decade of discoveries, defects and disputes," Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders, vol. 4, no. 2, pp. 62-73, 2003. (Pubitemid 36874774)
67. L. Zinman, H. N. Liu, C. Sato et al., "A mechanism for low penetrance in an ALS family with a novel SOD1 deletion," Neurology, vol. 72, no. 13, pp. 1153-1159, 2009.
68. P. Pasinelli and R. H. Brown, "Molecular biology of amyotrophic lateral sclerosis: insights from genetics," Nature Reviews Neuroscience, vol. 7, no. 9, pp. 710-723, 2006. (Pubitemid 44267495)
69. K. Nishiyama, S. Murayama, S. Kwak, and I. Kanazawa, "Expression of the copper-zinc superoxide dismutase gene in amyotrophic lateral sclerosis," Annals of Neurology, vol. 41, no. 4, pp. 551-556, 1997. (Pubitemid 27169196)
70. F. L. Conforti, A. Magariello, R. Mazzei et al., "Abnormally high levels of SOD1 mRNA in a patient with amyotrophic lateral sclerosis," Muscle and Nerve, vol. 29, no. 4, pp. 610-611, 2004. (Pubitemid 38451355)
71. Y. M. Jiang, M. Yamamoto, Y. Kobayashi et al., "Gene expression profile of spinal motor neurons in sporadic amyotrophic lateral sclerosis," Annals of Neurology, vol. 57, no. 2, pp. 236-251, 2005. (Pubitemid 40179862)
72. X. S.Wang, Z. Simmons,W. Liu, P. Boyer, and J. Connor, "Differential expression of genes in amyotrophic lateral sclerosis revealed by profiling the post mortem cortex," Amyotrophic Lateral Sclerosis, vol. 7, no. 4, pp. 201-216, 2006. (Pubitemid 46290908)
73. S.Gagliardi, E. Cova, A. Davin et al., "SOD1mRNA expression in sporadic amyotrophic lateral sclerosis," Neurobiology of Disease, vol. 39, no. 2, pp. 198-203, 2010.
74. E. Cova, C. Cereda, A. Galli et al., "Modified expression of Bcl-2 and SOD1 proteins in lymphocytes from sporadic ALS patients," Neuroscience Letters, vol. 399, no. 3, pp. 186-190, 2006. (Pubitemid 44308127)
75. S.M.Chou, C. Y.Han, H. S.Wang,H.Vlassara, andR. Bucala, "A receptor for advanced glycosylation endproducts (AGEs) is colocalized with neurofilament-bound AGEs and SOD1 in motoneurons of ALS: immunohistochemical study," Journal of the Neurological Sciences, vol. 169, no. 1-2, pp. 87-92, 1999. (Pubitemid 29502513)
76. S.Matsumoto,H. Kusaka,H. Ito, N. Shibata, T. Asayama, and T. Imai, "Sporadic amyotrophic lateral sclerosis with dementia and Cu/Zn superoxide dismutase-positive Lewy body-like inclusions," Clinical Neuropathology, vol. 15, no. 1, pp. 41-46, 1996. (Pubitemid 26022736)
77. N. Shibata, A. Hirano,M. Kobayashi et al., "Cu/Zn superoxide dismutase-like immunoreactivity in Lewy body-like inclusions of sporadic amyotrophic lateral sclerosis,"Neuroscience Letters, vol. 179, no. 1-2, pp. 149-152, 1994. (Pubitemid 24298580)
78. A. Gruzman, W. L. Wood, E. Alpert et al., "Common molecular signature in SOD1 for both sporadic and familial amyotrophic lateral sclerosis," Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 30, pp. 12524-12529, 2007. (Pubitemid 47206171)
79. K. Forsberg, P. A. Jonsson, P. M. Andersen et al., "Novel antibodies reveal inclusions containing non-native SOD1 in sporadic ALS patients," PLoS One, vol. 5, no. 7, Article ID e11552, 2010.
80. D. A. Bosco, G. Morfini, N. M. Karabacak et al., "Wild-type and mutant SOD1 share an aberrant conformation and a common pathogenic pathway in ALS," Nature Neuroscience, vol. 13, no. 11, pp. 1396-1403, 2010.
81. J. D. Rothstein, "Current hypotheses for the underlying biology of amyotrophic lateral sclerosis," Annals of Neurology, vol. 65, no. 1, pp. S3-S9, 2009.
82. M. Watanabe, M. Dykes-Hoberg, V. Cizewski Culotta, D. L. Price, P. C. Wong, and J. D. Rothstein, "Histological evidence of protein aggregation in mutant SOD1 transgenic mice and in amyotrophic lateral sclerosis neural tissues," Neurobiology of Disease, vol. 8, no. 6, pp. 933-941, 2001. (Pubitemid 34017087)